Andrew Barnhill is a pharmaceutical government affairs executive with experience at Fortune 500 companies and a diverse set of healthcare coalitions and political campaigns at the state and federal level, Barnhill currently serves as Head of Public Policy for BioDelivery Sciences where he is responsible for all government affairs and sits on the leadership team, reporting to the Chief Medical Officer. He previously served as Director for Federal Policy for GlaxoSmithKline. At GSK, Barnhill was responsible for policy development and internal and external thought leadership on federal issues. He also led GSK's engagement strategy with federal agencies, specifically the Department of Health & Human Services and the company's response to the White House Blueprint on Drug Pricing.
Barnhill’s teaching and research interests are concentrated in the politics of healthcare, the ethics of health policy, and legislative process. An advocate for value-based healthcare payment reform, Barnhill has a specific interest in the interaction between governments, the private sector, and nongovernmental organizations, including faith-based partnerships. He teaches Introduction to Public Policy and other courses in healthcare policy.
A graduate of Duke University, the University of North Carolina, and Furman University, with graduate studies at University of Oxford, Barnhill holds degrees in law (JD), ethics, and policy. He also completed the executive program in pharmaceutical management at Cornell. Barnhill was the 2016 Democratic Nominee for North Carolina Senate in the 9th District in a competitive race that garnered national attention by multiple national news outlets where he was endorsed by President Barack Obama. Previously, Barnhill worked on Capitol Hill, at a national lobbying firm, and as a political campaign media consultant. A native of North Carolina with a home on the Carolina coast, Barnhill lives in Washington, DC and commutes weekly to Manhattan.
